• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-DR 标记活动性结核患者中最近分化的抗原特异性效应性 CD4 T 细胞。

HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.

机构信息

Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.

Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.

出版信息

J Immunol. 2021 Jul 15;207(2):523-533. doi: 10.4049/jimmunol.2100011. Epub 2021 Jun 30.

DOI:10.4049/jimmunol.2100011
PMID:34193602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516689/
Abstract

Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to -sensitized healthy IGRA individuals. We found that the frequency of HLA-DR cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in Ag-specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.

摘要

当遇到抗原时,T 细胞可以迅速分裂并形成效应细胞群体,这在对抗急性感染中起着重要作用。在人类中,对于区分这种效应细胞与其他 T 细胞群体的分子标记知之甚少。为了解决这个问题,我们研究了活跃性肺结核(ATB)个体中存在的 T 细胞的分子特征,我们预计在这些个体中,抗原接触和效应细胞的扩增会更频繁地发生,与致敏的健康 IGRA 个体相比。我们发现,循环 CD4 T 细胞中 HLA-DR 细胞的频率在 ATB 患者中增加,并且主要在 Ag 特异性 CD4 T 细胞中表达。我们使用体外模型检测了健康 IGRA 个体的静止记忆 T 细胞对 Ag 的反应,测试并证实 HLA-DR 是 Ag 暴露后新近分裂的 CD4 T 细胞的标志物。因此,HLA-DR 标记了一个可以在人类外周血中直接检测到的 CD4 T 细胞群体,其在 ATB 疾病期间增加,并包含最近分裂的 Ag 特异性效应 T 细胞。这些发现将有助于监测和研究 ATB 及其他感染情况下的疾病特异性效应 T 细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/8807179e8cea/nihms-1704979-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/b047bfe2200c/nihms-1704979-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/3a37856bf1db/nihms-1704979-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/ee40ed47eb05/nihms-1704979-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/6d61b56db8f0/nihms-1704979-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/8807179e8cea/nihms-1704979-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/b047bfe2200c/nihms-1704979-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/3a37856bf1db/nihms-1704979-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/ee40ed47eb05/nihms-1704979-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/6d61b56db8f0/nihms-1704979-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198c/8516689/8807179e8cea/nihms-1704979-f0005.jpg

相似文献

1
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.HLA-DR 标记活动性结核患者中最近分化的抗原特异性效应性 CD4 T 细胞。
J Immunol. 2021 Jul 15;207(2):523-533. doi: 10.4049/jimmunol.2100011. Epub 2021 Jun 30.
2
Activation Phenotype of -Specific CD4 T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection.-特异性 CD4 T 细胞激活表型促进活动性结核病与潜伏性结核感染的鉴别。
Front Immunol. 2021 Aug 26;12:721013. doi: 10.3389/fimmu.2021.721013. eCollection 2021.
3
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.结核分枝杆菌特异性 CD4 T 细胞表型变化作为结核病治疗效果的替代标志物。
Front Immunol. 2018 Sep 28;9:2247. doi: 10.3389/fimmu.2018.02247. eCollection 2018.
4
Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.患者T细胞上的生物标志物可诊断活动性结核病并监测治疗反应。
J Clin Invest. 2015 May;125(5):1827-38. doi: 10.1172/JCI77990. Epub 2015 Mar 30.
5
Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4 T cell responses restricted by single HLA class II allotype in an individual.个体中由单个 HLA Ⅱ类同种异型限制的结核分枝杆菌抗原特异性 CD4 T 细胞反应的综合分析。
Front Immunol. 2022 Jul 28;13:897781. doi: 10.3389/fimmu.2022.897781. eCollection 2022.
6
Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis.循环 HLA-DR+CD4+效应记忆 T 细胞对 CCR5 和 PD-L1 介导的抑制具有抗性,从而损害结核分枝杆菌中调节性 T 细胞的功能。
PLoS Pathog. 2018 Sep 19;14(9):e1007289. doi: 10.1371/journal.ppat.1007289. eCollection 2018 Sep.
7
Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.人巨细胞病毒抗原由 HLA-DR+NKG2C+适应性 NK 细胞呈递,特异性激活多功能效应记忆 CD4+T 淋巴细胞。
Front Immunol. 2019 Apr 3;10:687. doi: 10.3389/fimmu.2019.00687. eCollection 2019.
8
Diagnostic Value of CD25, CD69, and CD134 on Tuberculosis-Specific Antigen-Stimulated CD4+ T Cells for Tuberculous Pleurisy.结核特异性抗原刺激 CD4+T 细胞 CD25、CD69、CD134 的表达对结核性胸膜炎的诊断价值。
J Immunol Res. 2023 Sep 27;2023:5309816. doi: 10.1155/2023/5309816. eCollection 2023.
9
Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.使用 HLA-DR*08032/E7 和 HLA-DR*0818/E7 四聚体来跟踪活动期和恢复期结核患者与对照供体之间的表位特异性 CD4+T 细胞。
Immunobiology. 2011 Aug;216(8):947-60. doi: 10.1016/j.imbio.2011.01.003. Epub 2011 Jan 12.
10
Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.重组分枝杆菌65-kDa热休克蛋白诱导抗原特异性CD4 + HLA-DR限制性细胞毒性T淋巴细胞以及非特异性非限制性杀伤细胞。
Eur J Immunol. 1990 Feb;20(2):369-77. doi: 10.1002/eji.1830200221.

引用本文的文献

1
Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases.结核病索引病例密切接触者队列中免疫细胞亚群差异极小。
bioRxiv. 2025 Aug 4:2025.08.04.668387. doi: 10.1101/2025.08.04.668387.
2
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs .zeste同源物1/2双重抑制剂瓦列莫司他在重新激活潜伏的HIV-1储存库方面优于zeste同源物2选择性抑制剂。
Front Microbiol. 2025 Apr 10;16:1581330. doi: 10.3389/fmicb.2025.1581330. eCollection 2025.
3
Single-Cell Analysis Reveals Tissue-Specific T Cell Adaptation and Clonal Distribution Across the Human Gut-Liver-Blood Axis.

本文引用的文献

1
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 T Cells in COVID-19.COVID-19 中 SARS-CoV-2 反应性调节性和细胞毒性 CD4 T 细胞的失衡。
Cell. 2020 Nov 25;183(5):1340-1353.e16. doi: 10.1016/j.cell.2020.10.001. Epub 2020 Oct 5.
2
Disease extent and anti-tubercular treatment response correlates with -specific CD4 T-cell phenotype regardless of HIV-1 status.疾病程度和抗结核治疗反应与特异性CD4 T细胞表型相关,无论HIV-1状态如何。
Clin Transl Immunology. 2020 Sep 28;9(9):e1176. doi: 10.1002/cti2.1176. eCollection 2020.
3
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
单细胞分析揭示了组织特异性T细胞适应性以及跨人类肠道-肝脏-血液轴的克隆分布。
bioRxiv. 2025 Mar 14:2025.03.11.642626. doi: 10.1101/2025.03.11.642626.
4
Cytolytic γδ T-cells and IFNγ-producing CD4-lymphocytes characterise the early response to MTBVAC tuberculosis vaccine.细胞溶解性γδ T细胞和产生IFNγ的CD4淋巴细胞是对MTBVAC结核病疫苗早期反应的特征。
NPJ Vaccines. 2025 Mar 28;10(1):58. doi: 10.1038/s41541-025-01110-3.
5
sEV-mediated intercellular transformation from MGAT4A to MGAT4A tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL.小细胞外囊泡(sEV)通过HOTAIRM1/miR-196b-5p轴介导从MGAT4A细胞到MGAT4A肿瘤细胞的细胞间转化,促进蕈样肉芽肿(CTCL)中的细胞凋亡抗性。
Oncogene. 2025 Mar 28. doi: 10.1038/s41388-025-03356-6.
6
EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk Reduction.二十碳五烯酸(EPA)在T细胞中诱导抗炎转录组,提示存在一条不依赖甘油三酯的降低心血管风险途径。
JACC Basic Transl Sci. 2025 Mar;10(3):383-395. doi: 10.1016/j.jacbts.2024.09.002. Epub 2024 Oct 30.
7
HIV co-infection is associated with increased HLA-DR expression by Mycobacterium tuberculosis-specific CD4 T cells in people with latent tuberculosis infection.在潜伏性结核感染人群中,HIV合并感染与结核分枝杆菌特异性CD4 T细胞的HLA-DR表达增加有关。
Tuberculosis (Edinb). 2025 Mar;151:102607. doi: 10.1016/j.tube.2025.102607. Epub 2025 Jan 20.
8
Impaired -specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in Uganda.乌干达 2 型糖尿病患者中受损的特异性 T 细胞记忆表型和功能特征。
Front Immunol. 2024 Oct 4;15:1480739. doi: 10.3389/fimmu.2024.1480739. eCollection 2024.
9
Increased Activation Markers of Adaptive Immunity in Patients with Severe COVID-19.重症新型冠状病毒肺炎患者适应性免疫激活标志物增加。
J Clin Med. 2024 Sep 24;13(19):5664. doi: 10.3390/jcm13195664.
10
Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity.肿瘤微环境中的氯化钠增强了 T 细胞的代谢适应性和细胞毒性。
Nat Immunol. 2024 Oct;25(10):1830-1844. doi: 10.1038/s41590-024-01918-6. Epub 2024 Aug 28.
SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
4
Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis.结核分枝杆菌特异性 CD4 T 细胞表达 CD153 与人类结核病的细菌载量和疾病严重程度呈负相关。
Mucosal Immunol. 2021 Mar;14(2):491-499. doi: 10.1038/s41385-020-0322-6. Epub 2020 Jul 16.
5
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.深度免疫剖析 COVID-19 患者,揭示具有治疗意义的不同免疫类型。
Science. 2020 Sep 4;369(6508). doi: 10.1126/science.abc8511. Epub 2020 Jul 15.
6
Comprehensive mapping of immune perturbations associated with severe COVID-19.全面绘制与严重 COVID-19 相关的免疫扰动图谱。
Sci Immunol. 2020 Jul 15;5(49). doi: 10.1126/sciimmunol.abd7114.
7
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.不同疾病严重程度的 COVID-19 患者的实验室检测和宿主免疫。
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
8
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.患者康复前伴随免疫反应的广度:非重症COVID-19病例报告
Nat Med. 2020 Apr;26(4):453-455. doi: 10.1038/s41591-020-0819-2.
9
Cutting Edge: Characterization of Human Tissue-Resident Memory T Cells at Different Infection Sites in Patients with Tuberculosis.前沿:结核患者不同感染部位组织驻留记忆 T 细胞的特征。
J Immunol. 2020 May 1;204(9):2331-2336. doi: 10.4049/jimmunol.1901326. Epub 2020 Mar 30.
10
Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease.登革病毒特异性 IL-10/IFN-γ 共表达 CD4+T 细胞的分子特征及其与登革热疾病的关系。
Cell Rep. 2019 Dec 24;29(13):4482-4495.e4. doi: 10.1016/j.celrep.2019.11.098.